Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6
RIPK4 has been implicated in multiple cancer types, but its role in ovarian cancer (OC) has not been clearly elucidated. Our data from Gene Expression Profiling Interactive Analysis, RT-PCR, and immunohistochemical analysis showed that RIPK4 was expressed at higher levels in OC tissues and cells tha...
Saved in:
Main Authors: | Huan Yi, Yan-zhao Su, Rong Lin, Xiang-qin Zheng, Diling Pan, Dan-mei Lin, Xiang Gao, Rong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/8875450 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of breast cancer cell invasion and epithelial – mesenchymal transition by Sanhuang decoction through the downregulation of CXCL8 secretion from mesenchymal stem cells
by: Yu-tong Bai, et al.
Published: (2025-02-01) -
Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
by: Taha Umair Wani, et al.
Published: (2025-01-01) -
Exosomal miR-543 Inhibits the Proliferation of Ovarian Cancer by Targeting IGF2
by: Shupei Zhang, et al.
Published: (2022-01-01) -
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01) -
Opioid System and Epithelial–Mesenchymal Transition
by: Marzena Łazarczyk, et al.
Published: (2025-01-01)